What is Vera Therapeutics's short- term investments?

Vera Therapeutics (VERA) reported short- term investments of $482.41M in Q1 2026.

How has Vera Therapeutics's short- term investments changed year-over-year?

Vera Therapeutics's short- term investments decreased by 9.8% year-over-year, from $534.74M to $482.41M.

Vera Therapeutics VERA Short- term Investments

Short- term Investments at other companies

Vertex PharmaceuticalsVRTX

——

ImmunityBio, Inc.IBRX

——

BiohavenBHVN

——

Merck & Co.MRK

——

Johnson & JohnsonJNJ

——

CRISPR TherapeuticsCRSP

——

Other financials

Income statement

See full

Operating income-$125.1M-119%

Net income-$121.0M-134%

EPS (diluted)-$1.69-109%

Balance sheet

See full

Cash & equivalents$114.4M+108%

Total debt$75.0M+37.8%

Total equity$499.7M-6.6%

Total assets$621.7M+1.9%

Cash flow

See full

Operating cash flow-$106.5M-95.8%

CapEx$23.0K-87.7%

Free cash flow-$106.5M-95.1%

Valuation

See full

Market cap$2.74B+87.5%

Enterprise value$2.7B+85.0%

Returns & leverage

See full

Return on equity-71.3%+296pp

Debt / equity0.2×0.0×

Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vera Therapeutics's short- term investments?: Vera Therapeutics (VERA) reported short- term investments of $482.41M in Q1 2026.
How has Vera Therapeutics's short- term investments changed year-over-year?: Vera Therapeutics's short- term investments decreased by 9.8% year-over-year, from $534.74M to $482.41M.